Lisa Bodei, MD, PhD

Pretty packed at the Theranostics in NETs session!

Green nuclear medicine and theranostics: debate and discussion. ow.ly/pMGa50VgahK #NuclearMedicine #Theranostics #MolecularImaging @ProfKHerrmann

“Being a woman in nuclear medicine comes with the responsibility to recruit, support, and empower more women in this field."

"I believe that my identity as a woman in this discipline enhances the application of a well-rounded and multifaceted approach to scientific exploration.”

"Women bring unconditional strength, support, and dedication to whatever role inspires them personally or professionally.”

"My leadership journey has reinforced the power of visibility: 'You can't be what you can't see.' I hope my role inspires others to pursue leadership, even if they once doubted their place in this field.”

Today is International Women's Day, and SNMMI celebrates all of the trailblazing women in the nuclear medicine field whose expertise, passion, and dedication contribute to the highest standards of patient care.

Reflections on the demand for PSMA- and SSTR-targeted radiopharmaceutical therapies: Why we were wrong (and why we will be right eventually). ow.ly/T40950UYrU2 #RPTherapy #NuclearMedicine #Theranostics @CalaisJeremie @lisabodei @CzerninJohannes

Join us for episode 6 of the JNM podcast. Moderator Ken Herrmann, MD is joined by Simron Singh, MD and Lisa Bodei, MD, PhD to discuss NETTER-2, the first trial to examine radioligand therapy as a first-line therapy for cancers. Full episode here: youtu.be/whHhKf5fY8I

The hard copies of "Radiopharmaceutical Therapy" have arrived! Managed to get a pic with my Co-Editors…. The book really is the perfect stocking filler @lisabodei @TheZeglisLab

@LewisLabMSKCC @ProfKHerrmann @freddyeescorcia @LapiSuzanne @PougetLab @juliesut8 @DrMHofman @morr316 @syaterry Thank you, Jason, for your leadership in this great endeavor! Truly thank you and Brian for the wonderful collaboration and a big thank you to all the contributors for their excellent chapters !

Would not have been possible without all the amazing contributions from our colleagues around the globe! @ProfKHerrmann @freddyeescorcia @LapiSuzanne @PougetLab @juliesut8 @DrMHofman @morr316 @syaterry and so many others....

Thank you, Jason!!! Such a fantastic endeavor! Without you and Brian it would never have been possible

Coming in the fall 2023. So proud to have been a part of this fantastic endeavor! Everything about RPT. @LewisLabMSKCC @TheZeglisLab

@thomashopemd @lawhn Such a fun experience! Great leadership by Courtney @lawhn !

Hope everyone is at the knowledge bowl arguing over bremsstrahlung. DOTA-mates for the win. Go @lawhn and @lisabodei.

We will also have a tumor board focused on clinical applications of PSMA-targeted radioligand therapy. What an amazing panel including @morr316 @lisabodei @TubaKendi @CalaisJeremie. See what people think of cases like this. Looking forward to seeing everyone bright and early!

New Guideline Alert! Joint #SNMMI #EANM guideline for Lu-177 PSMA-targeted therapy will help practitioners select high-potential patients and prepare for clinical management. Thanks @EANM_NucMed! ow.ly/g7Ls50OKN8q #NuclearMedicine #RPTherapy #ProstateCancer

Excited to announce the release of the @SNM_MI consensus statement on PSMA RLT. We attempted to wrangle with a number of difficult questions about how to use PSMA RLT in clinical practice. Check it out at: jnm.snmjournals.org/content/early/…

Amazing Keynote by @lisabodei before tonight’s opening ceremony #ISRS2023

Panelists are Dr.(s) Tara Masten, @CaterinaRamogi1, Danielle Vugts, and @lisabodei!

1. For the first @SNMMI_CIC case, @lisabodei from @MSKCancerCenter presents a case of #PSMARLT where FDG PET, post-treatment SPECT and MRI all play a role in understanding response. Please watch the full video at bit.ly/3Bw5kDm.